# A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-novel-dosing-approach-for-rituximab-in-glomerular-diseases-based-on-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jan Miroslav Hartinger,Martin Šíma,Zdenka Hrušková,Alena Pilková,Vojtěch Krátký,Romana Ryšavá,Eva Jančová,Daniel Bobek,Jiří Douša,Ivana Francová,Vladimı́r Tesař,Ondřej Slanař |
| Citations | 15 |
| DOI | 10.1016/j.biopha.2024.116655 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.1016/j.biopha.2024.116655 |
| OpenAlex ID | https://openalex.org/W4395699833 |
| PMID | 38678967 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Jan Miroslav Hartinger](https://scholariq.org/researchers/jan-miroslav-hartinger/)

## Paper journal

- [Biomedicine & Pharmacotherapy](https://scholariq.org/journals/biomedicine-and-pharmacotherapy/)

## Paper primary topic

- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)

## Paper topics

- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.